Systematic Reviews
Copyright ©The Author(s) 2015.
World J Gastroenterol. Dec 7, 2015; 21(45): 12896-12953
Published online Dec 7, 2015. doi: 10.3748/wjg.v21.i45.12896
Table 9 Characteristics of available systematic review and/or meta-analyses, reported in English, assessing the association between hepatitis C virus infection and lymphomas
First author/CountryTitleNumber of studies consideredMain conclusionMatching factors considered
Gisbert JP, 2003Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis23HCV prevalence in patients with B-NHL is approximately 15%, higher than that reported not only in general population (1.5%) but also in patients with other hematologic malignancies (2.9%), suggesting a role of HCV in the etiology of B-NHLAge, sex, smoking, race, when available
Matsuo K, 2004Effect of hepatitis C virus infection on the risk of non-Hodgkin’s lymphoma: a meta-analysis of epidemiological studies23Strongly positive association between anti-HCV seropositive test subjects and risk of NHL. Individualists with anti-HCV positive test have approximately five times higher risk of NHL. This association is consistent regardless of the endemic status of HCV, as well as subgroup analysis for B-/T-NHLAge and sex, when available
Negri E, 2004B-cell non-Hodgkin’s lymphoma and hepatitis C virus infection: a systematic review15A high HCV prevalence in B-NHL was found in southern and eastern Europe, Japan and the southern United States, but not in central and northern Europe, Canada, northern United States, or a few Asian countries. The odds ratio of B-NHL for HCV infection was relatively weak, ranging from 2 to 4 in most studies. Thus, even if the observed association were causal, the percentage of cases of B-NHL attributable to HCV infection would be relatively low (10%) also in countries with a high prevalence of HCV infection in the general population, and extremely low in other countriesAge and sex, whether available
Dal Maso L, 2006Hepatitis C Virus and Risk of Lymphoma and Other Lymphoid Neoplasms: A Meta-analysis of Epidemiologic Studies18The pooled relative risks (RR) were consistently increased for all major B-NHL subtypes, T-NHL, and primary sites of NHL presentation. The etiologic fraction of NHL attributable to HCV varies greatly by country, and may be upward of 10% in areas,where HCV prevalence is high .Associations weaker than with NHL were found between HCV infection and Hodgkin’s lymphomaAge and sex, when available
de Sanjose S, 2008Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium7The results of the present study confirm the association between HCV infection and NHL and specific B-NHL subtypes (diffuse large B-cell lymphoma, marginal zone lymphoma and lymphoplasmacytic lymphoma). This research has sufficient statistical power to confirm these associations in populations with low HCV prevalenceAge, sex, county of residence, study site, geographic area, when available
Libra M, 2010Extrahepatic disorders of HCV infection: A distinct entity of B-cell neoplasia?18 Review of Italian studiesThe results of the study confirm the association between HCV infection and NHL and specific B-NHL subtypes. The higher prevalence of anti-HCV Abs was observed among lymphoplasmacytoid/lymphoplasmacytic/immunocytoma histotype whereas the lowest was among small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL). Overall, these studies strongly support the notion that HCV-associated lymphomas may be a distinct entity and further characterization of the mechanisms by which HCV infection contributes to B-cell NHL development may improve its diagnosis, classification and treatmentNR

  • Citation: Fiorino S, Bacchi-Reggiani L, de Biase D, Fornelli A, Masetti M, Tura A, Grizzi F, Zanello M, Mastrangelo L, Lombardi R, Acquaviva G, di Tommaso L, Bondi A, Visani M, Sabbatani S, Pontoriero L, Fabbri C, Cuppini A, Pession A, Jovine E. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. World J Gastroenterol 2015; 21(45): 12896-12953
  • URL: https://www.wjgnet.com/1007-9327/full/v21/i45/12896.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v21.i45.12896